Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.

We have determined that expression of the c-myb proto-oncogene is associated with estrogen receptor (ER) status and not with tumor progression in human breast epithelial cells. Analysis of normal, immortalized, nontumorigenic, and tumorigenic mammary epithelial cells showed that only ER+ tumor cell lines expressed readily detectable levels of c-myb mRNA and a Mr 75,000 protein that was the same size as the c-myb transcripts and protein products present in hematopoietic cells. In this report we show that c-myb mRNA and protein levels are down-regulated during estrogen withdrawal. A 20-fold increase in c-myb mRNA and protein expression was observed upon addition of beta-estradiol to the culture medium. Nuclear run-on transcription analyses showed that c-myb was transcribed at the same rate in the presence and absence of estrogen, suggesting that c-myb mRNA accumulation was regulated at a posttranscriptional level. To provide additional evidence that c-myb mRNA was dependent on ER expression, we examined c-myb mRNA levels in MCF-7 cells selected for resistance to antineoplastic drugs. c-myb expression was decreased only in cell lines that showed concomitant loss of ER expression. Moreover, c-myb mRNA was expressed and modulated by estrogen in ER-, MDA-MB-231 cells stably transfected with a human ER gene. When considered together, these data indicate that c-myb mRNA levels are regulated by estrogens and further suggest that this proto-oncogene plays a role in the biology of ER+ breast tumor cells.

[1]  M. Israel,et al.  Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation , 1988, Molecular and cellular biology.

[2]  R. Clarke,et al.  Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. , 1992, Critical reviews in oncology/hematology.

[3]  R. Eisenman,et al.  A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5'-disrupted myb loci , 1989, Molecular and cellular biology.

[4]  C. Griffin,et al.  Expression of the c-myb oncogene in human small cell lung carcinoma. , 1985, Cancer research.

[5]  E. Westin,et al.  Identification of a second promoter in the human c-myb proto-oncogene. , 1994, Oncogene.

[6]  O. Petersen,et al.  Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. , 1987, Cancer research.

[7]  E Marshall,et al.  Epidemiology. Search for a killer: focus shifts from fat to hormones , 1993, Science.

[8]  S. Ferrari,et al.  Activation of c-myb expression by phytohemagglutinin stimulation in normal human T lymphocytes , 1985, Molecular and cellular biology.

[9]  R. Eisenman,et al.  New light on Myc and Myb. Part I. Myc. , 1990, Genes & development.

[10]  R. Watson,et al.  Expression of the c-myb and c-myc genes is regulated independently in differentiating mouse erythroleukemia cells by common processes of premature transcription arrest and increased mRNA turnover , 1988, Molecular and cellular biology.

[11]  K. Cowan,et al.  Selenium-dependent glutathione peroxidase expression is inversely related to estrogen receptor content of human breast cancer cells. , 1991, Cancer communications.

[12]  W. Marzluff,et al.  Multiple regulatory steps control histone mRNA concentrations. , 1988, Trends in biochemical sciences.

[13]  J. Mushinski,et al.  Alternative splicing of RNAs transcribed from the human c-myb gene , 1990, Molecular and cellular biology.

[14]  R. Dodson,et al.  An estrogen-inducible protein binds specifically to a sequence in the 3' untranslated region of estrogen-stabilized vitellogenin mRNA , 1994, Molecular and cellular biology.

[15]  K. Cowan,et al.  Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Katzenellenbogen,et al.  Hormone binding and transcription activation by estrogen receptors: Analyses using mammalian and yeast systems , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  M. Schwab,et al.  Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Calabretta,et al.  c-myb and growth control. , 1992, Critical reviews in eukaryotic gene expression.

[19]  M. Stampfer,et al.  Human mammary epithelial cells in culture: differentiation and transformation. , 1988, Cancer treatment and research.

[20]  N Andrieu,et al.  Strong association between c-myb and oestrogen-receptor expression in human breast cancer. , 1990, Oncogene.

[21]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[22]  M. Brock,et al.  Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation , 1983, Cell.

[23]  G. Shen-Ong.  Alternative internal splicing in c‐myb RNAs occurs commonly in normal and tumor cells. , 1987, The EMBO journal.

[24]  S. Cory,et al.  Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias , 1987, Journal of virology.

[25]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[26]  L. Boise,et al.  Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation. , 1992, Oncogene.

[27]  R. Dalla‐Favera,et al.  Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Calabretta,et al.  Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene , 1991, Molecular and cellular biology.

[29]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[30]  H. Rochefort,et al.  Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Chambon,et al.  Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[33]  K. Cowan,et al.  A pleiotropic response associated with resistance of breast cancer cells to antineoplastic drugs and hormonal agents. , 1988, Trends in pharmacological sciences.

[34]  G. Mizuguchi,et al.  Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. , 1992, Oncogene.

[35]  D. Crabb,et al.  Estradiol regulates class I alcohol dehydrogenase gene expression in renal medulla of male rats by a post-transcriptional mechanism. , 1992, Archives of biochemistry and biophysics.

[36]  Sam W. Lee,et al.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Graf,et al.  The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene , 1989, Cell.

[38]  J. Hayman,et al.  Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[39]  K. Cowan,et al.  Structure and function of the 5'-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene (hgpx1). , 1992, The Journal of biological chemistry.

[40]  P. Darbre.  6. Steroids and steroid receptors in growth control of cultured breast cancer cells , 1990 .

[41]  K. Smith,et al.  Interleukin-2 induction of T-cell G1 progression and c-myb expression. , 1986, Science.

[42]  J. Bishop,et al.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb , 1989, Cell.

[43]  P. Darbre,et al.  Effect of estradiol on human breast cancer cells in culture. , 1983, Cancer research.

[44]  S. Steinberg,et al.  A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  V. Jordan,et al.  Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. , 1992, Journal of the National Cancer Institute.

[46]  P. Chambon,et al.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.

[47]  J. Lipsick,et al.  Expression of the CD4 gene requires a Myb transcription factor , 1992, Molecular and cellular biology.

[48]  R. Coombes,et al.  Breast Estrogen and Progesterone Receptors in the Normal Female Updated Version , 2006 .

[49]  S. Ishii,et al.  Characterization of alternate and truncated forms of murine c-myb proteins. , 1989, Oncogene research.

[50]  R. Shiu,et al.  Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. , 1988, The Journal of biological chemistry.

[51]  T. Graf,et al.  Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene , 1982, Cell.

[52]  W. Kuehl,et al.  Mechanism of c-myc regulation by c-Myb in different cell lineages , 1993, Molecular and cellular biology.

[53]  B. Calabretta,et al.  c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene. , 1993, The Journal of biological chemistry.

[54]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Cowan,et al.  Posttranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells. , 1992, The Journal of biological chemistry.

[56]  R. Eisenman,et al.  New light on Myc and Myb. Part II. Myb. , 1990, Genes & development.

[57]  G. B. Knight,et al.  Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Sager,et al.  Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. , 1991, Molecular endocrinology.

[59]  P. Darbre.  Steroids and steroid receptors in growth control of cultured breast cancer cells. , 1990, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[60]  J. Fridovich-Keil,et al.  Posttranscriptional control of thymidine kinase messenger RNA accumulation in cells released from G0-G1 phase blocks. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[61]  R. Hoover,et al.  Rising incidence of breast cancer: relationship to stage and receptor status. , 1990, Journal of the National Cancer Institute.

[62]  Michael E. Greenberg,et al.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene , 1984, Nature.

[63]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[64]  M. Baluda,et al.  Morphological conversion of cell cultures by avian myeloblastosis virus. , 1961, Virology.